| Dr Richard A Roche, DDS | |
|
800 W Diamond St, Butte, MT 59701 | |
| (406) 723-8627 | |
| Not Available |
| Full Name | Dr Richard A Roche |
|---|---|
| Gender | Male |
| Speciality | Dentist |
| Location | 800 W Diamond St, Butte, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578617668 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 1121 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard A Roche, DDS 800 W Diamond St, Butte, MT 59701 Ph: (406) 723-8627 | Dr Richard A Roche, DDS 800 W Diamond St, Butte, MT 59701 Ph: (406) 723-8627 |
News Archive
Conflicts and wars not only take their toll on human lives, but also on the local environment. Whilst much publicity is focused on International efforts to help rebuild Afghanistan's economy and social structures, less well known is the - often voluntary - work going on to rebuild the environment, part of which involves the planting of millions of trees, as a more green environment helps to improve the dusty landscape damaged by years of fighting. More greenery also means cleaner air.
Fluidigm Corporation today announced it has developed the world's first reusable bio-chip architecture for the commercial market. These reusable integrated fluidic circuits (IFCs) will dramatically lower SNP genotyping costs and are designed to support accelerated sample throughput, while maintaining data quality of 99.75 percent or greater accuracy and 99 percent or greater call rates.
Waters Corporation today launched a new program to support scientific innovation in the fields of health and life science research, sports science, food safety, clinical research and environmental protection.
Apellis Pharmaceuticals, Inc., today announced that it has completed a $47.1 million Series D preferred stock financing, co-led by new investors Cormorant Asset Management, Hillhouse Capital Group and venBio Global Strategic Fund, joining existing investors Morningside Venture Investments, AJU IB Investment, and Epidarex Capital.
In the study, published on the pre-print journal bioRxiv, the researchers revealed that SARS-CoV-2-infected EHTs manifested the typical characteristics of myocarditis or heart inflammation. These include the stimulation of immune cells, heart cell death, and decreased contractile force generation.
› Verified 3 days ago
Dr. Kara Bankiewicz, DMD Dentist Medicare: Medicare Enrolled Practice Location: 445 Centennial Ave, Butte, MT 59701 Phone: 406-723-4075 | |
Dr. Dennis E Janecke, DDS Dentist Medicare: Medicare Enrolled Practice Location: 238 S Idaho St, Butte, MT 59701 Phone: 406-498-7191 Fax: 406-723-3059 | |
Jere P Walters, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 238 S Idaho St, Butte, MT 59701 Phone: 406-782-8719 | |
Mr. Robert Franklyn Wilcox Ii, D.M.D Dentist Medicare: Not Enrolled in Medicare Practice Location: 2823 Lexington Ave, Butte, MT 59701 Phone: 406-494-4046 Fax: 406-494-7772 | |
Dr. Ryan Richard Todorovich, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 401 S Alabama St, Suite 3a, Butte, MT 59701 Phone: 406-498-6632 | |
Dr. Daniel Phillip Harrington, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1550 Harrison Ave, Butte, MT 59701 Phone: 406-782-1239 Fax: 406-782-1230 | |
Dr. William Dennis Brennick, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 820 Sampson St, Butte, MT 59701 Phone: 406-494-7080 Fax: 406-494-4634 |